Priscilla Hollander

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

Thomas A. Wadden, Priscilla Hollander, Samuel Klein et al. · International Journal of Obesity · 2013 · 820 citations

Agriculture, Nutrition, Nutritional Sciences +16

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

André Scheen, Nick Finer, Priscilla Hollander et al. · The Lancet · 2006 · 736 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

Priscilla Hollander, Steven C. Elbein, Irl B. Hirsch et al. · Diabetes Care · 1998 · 657 citations

Medicine, Pharmacology, Pharmacotherapy +17

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15